ABUS vs IT
Arbutus Biopharma Corp (ABUS) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ABUS and IT stock pages for the full models.
Not investment advice.